| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.4M | -10.4% | -4.9% |
| Cost of Revenue | $2.2M | -15.8% | -11.7% |
| Gross Profit | $1.2M | +1.5% | +11.3% |
| R&D Expense | $45K | -4.3% | -8.2% |
| SG&A Expense | $788K | -27.0% | -7.8% |
| Operating Income | -$134K | +67.2% | +50.4% |
| Net Income | -$122K | +68.6% | +49.2% |
| EPS (Basic) | -$0.01 | +75.0% | +50.0% |
| EPS (Diluted) | -$0.01 | +75.0% | +50.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $1.6M | +69.0% | +73.0% |
| Inventory | $3.2M | +3.2% | +3.8% |
| Current Assets | $7.5M | -7.2% | -21.6% |
| Total Assets | $8.8M | -6.5% | -20.8% |
| Current Liabilities | $3.2M | -11.7% | -37.7% |
| Total Liabilities | $4.0M | -11.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.3M | — | — |
| Capital Expenditures | $45K | — | — |
| Investing Cash Flow | -$45K | — | — |
| Financing Cash Flow | -$6K | — | — |
| Free Cash Flow | -$3.3M | — | — |
| -35.8% |
| Stockholders' Equity | $4.9M | -2.3% | -2.3% |